PHARMACIE MAGAIN: what changed
What changed
PHARMACIE MAGAIN
filed annual accounts (NBB)
Net result for the year
-
2023 · -€33+€33
Equity
€183,506
2023 · €183,506
Cash
€9,359
2023 · €9,359
Balance sheet total
€203,732
2023 · €203,732
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
No liability line moved by more than 1% of the balance sheet total.
Income statement
- Staff costs +€1,629
no longer reported in 2024 (was -€1,629)
- Gross operating margin +€1,461
no longer reported in 2024 (was -€1,461)
- Financial charges -€204
no longer reported in 2024 (was €204)
Change in the result, 2023 to 2024
The net result is not in both sets of accounts. Without it the difference cannot be explained line by line.
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €203,732 | €203,732 | = | 0.0% |
| Fixed assets | 21/28 | €3,153 | €3,153 | = | 0.0% |
| Financial fixed assets | 28 | €3,153 | €3,153 | = | 0.0% |
| Current assets | 29/58 | €200,578 | €200,578 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €191,220 | €191,220 | = | 0.0% |
| Other amounts receivable | 41 | €191,220 | €191,220 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €9,359 | €9,359 | = | 0.0% |
| Total equity and liabilities | 10/49 | €203,732 | €203,732 | = | 0.0% |
| Equity | 10/15 | €183,506 | €183,506 | = | 0.0% |
| Contributions | 10/11 | €6,205 | €6,205 | = | 0.0% |
| Reserves | 13 | €177,301 | €177,301 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €175,441 | €175,441 | = | 0.0% |
| Amounts payable | 17/49 | €20,226 | €20,226 | = | 0.0% |
| Amounts payable within one year | 42/48 | €20,226 | €20,226 | = | 0.0% |
| Trade debts | 44 | €19,785 | €19,785 | = | 0.0% |
| Suppliers | 440/4 | €19,785 | €19,785 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €441 | €441 | = | 0.0% |
| Taxes | 450/3 | €441 | €441 | = | 0.0% |
| Remuneration, social security and pensions | 62 | -€1,629 | - | +€1,629 | |
| Gross operating margin | 9900 | -€1,461 | - | +€1,461 | |
| Operating profit (loss) | 9901 | €168 | - | -€168 | |
| Financial income | 75/76B | €3 | - | -€3 | |
| Recurring financial income | 75 | €3 | - | -€3 | |
| Financial charges | 65/66B | €204 | - | -€204 | |
| Recurring financial charges | 65 | €204 | - | -€204 | |
| Profit (loss) for the period before taxes | 9903 | -€32 | - | +€32 | |
| Income taxes | 67/77 | €1 | - | -€1 | |
| Profit (loss) for the period | 9904 | -€33 | - | +€33 | |
| Profit (loss) for the period to be appropriated | 9905 | -€33 | - | +€33 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.